Applied Clinical Trials - Orphan products. (News Update).(SS1-PE38 monoclonal a
Posted on Monday, April 01 @ 08:00:00 CST by admin
April 1, 2002 -- FDA granted NeoPharm, Inc. (Lake Forest, IL) orphan drug status for its anti-mesothelin monoclonal antibody toxin, SS1-PE38, designed to treat ovarian ...
Click Here to read the entire article...
|
| |
|